Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
Key Highlights
- ➤Adaptive Biotechnologies will report Q3 2026 financial results November 4 after market close
- ➤Conference call begins November 4 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
- ➤Webcast will be available live and archived within 24 hours on company website
SEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the third quarter 2026 after market close on Wednesday, November 4, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event.
Get started
Create a free account to read the full story.